The Effect of Coffee on Energy Expenditure and Caffeine Metabolism

ConditionHealthy
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-40
SponsorShenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences

About this trial

Obesity is a risk factor for chronic diseases, and improving energy expenditure is a way to prevent and treat obesity. The purpose of this project is to explore the relationship between the effect of coffee on energy expenditure and caffeine metabolism, which has important significance in the rational application of caffeine.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Healthy adults.

Must be able to drink coffee.

Disqualifiers

Diabetes.

Hypoglycemia.

Gout.

Osteoporosis.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Caffeine content

    Other intervention

    Participants will drink the same volume of water or coffee, caffeine content is 2mg/kg by body weight.

Treatment groups

60 Participants
are divided into 2 treatment groups
Group A: waterExperimental treatment 1 intervention
Group B: coffeeExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Total energy expenditure

Total energy expenditure will be measured by Chamber (OMNICAL).

Time frame
2 days
2

The concentration of caffeine and its metabolites in urine

The contents of caffeine and it's metabolites will be measured by gas chromatography-mass spectrometry (GC-MS) and liquid chromatography-mass spectrometry (LC-MS ).

Time frame
2 days
3

The concentration of caffeine and its metabolites in serum

The concentration of caffeine and its metabolites in serum will be measured by gas chromatography-mass spectrometry (GC-MS) and liquid chromatography-mass spectrometry (LC-MS ).

Time frame
1 day

Secondary outcomes

1

Body temperature

Body temperature of participants will be measured by body temperature patch (RIT-P02-MED).

Time frame
2 days
2

Electrocardiogram (ECG)

ECG of participants will be measured by Amu ECG belt, the changes in P wave, PR interval, PR segment, QRS wave group, J point, ST segment, T wave, QT interval, and U wave will be observe.

Time frame
2 days
3

Blood pressure

Systolic and diastolic blood pressure of participants will be measured by Omron digital sphygmomanometer.

Time frame
2 days
4

Height

Height will be measured by seca 217 stable stadiometer. Subjects wearing no shoes.

Time frame
The morning of the first day of the experiment, 5 mins

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.